Regulatory and Effector T cells in Oral Immunotherapy for Food Allergy
Demographics (2)
- AGE - Subject age at enrollment (phv00420263.v2.p1)
- GENDER - Self-reported gender (phv00420264.v2.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00420265.v2.p1)
Other (17)
- AFFECTION_STATUS - Peanut allergy phenotype (Reactive or Hyporeactive; Reactive patients received peanut oral immunotherapy) (phv00420262.v2.p1)
- ANALYTE_TYPE - Analyte Type (phv00420272.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00420271.v2.p1)
- CLINICAL_OUTCOME_OF_TREATMENT - Clinical outcome of treatment with peanut oral immunotherapy (phv00420269.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00420258.v2.p1)
- CUMULATIVE_ELICITING_DOSE - Cumulative eliciting dose (mg peanut protein) at first objective allergic reaction during baseline double-blind placebo-controlled food challenge (phv00420266.v2.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00420273.v2.p1)
- IS_TUMOR - Tumor status (phv00420274.v2.p1)
- PEANUT_IGE - Peanut-specific IgE titer in plasma (kU/L) (phv00420268.v2.p1)
- POOLED_SAMPLE_ID - Sample ID (phv00420942.v2.p1)
- POOLING - Samples from these individual subjects are pooled in the corresponding pooled subject (phv00420941.v2.p1)
- SAMPLE_ID - Sample ID (phv00420270.v2.p1)
- SAMPLE_ID - Sample ID (phv00420260.v2.p1)
- SKIN_PRICK - Skin prick test wheal size (mm) in response to peanut allergen (phv00420267.v2.p1)
- SUBJECT_ID - Subject ID (phv00420261.v2.p1)
- SUBJECT_ID - Subject ID (phv00420257.v2.p1)
- SUBJECT_ID - Subject ID (phv00420259.v2.p1)